SCHEMBL19301647

SCHEMBL19301647

CC(C)c1ccc(F)nc1CC1CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23565849 0.81 KDM4E (0.39) —
SCHEMBL19301848 0.78 PDE2A (0.38) —
SCHEMBL18368373 0.77 GCGR (0.31) —
SCHEMBL19301849 0.76 HTR2A (0.34) —
SCHEMBL23566780 0.71 CXCR4 (0.40) —
SCHEMBL23565839 0.71 TSHR (0.41) —
SCHEMBL23566221 0.69 GABRP (0.38) —
SCHEMBL19284414 0.68 PTGER4 (0.41) —
SCHEMBL4734695 0.68 EIF4A3 (0.32) —
SCHEMBL12263281 0.66 LMNA (0.34) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11198681-B2 Heteroaryl inhibitors of PAD4 PADLOCK THERAPEUTICS, INC. (US) 2021-12-14 — — US disclosed
US-20210188810-A1 HETEROARYL INHIBITORS OF PAD4 PADLOCK THERAPEUTICS INC (US) 2021-06-24 — — US disclosed
WO-2017147102-A1 HETEROARYL INHIBITORS OF PAD4 PADLOCK THERAPEUTICS, INC. (US) 2017-08-31 — — WO disclosed
Send feedback